Person profile
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Roivant Sciences Ltd.
26 Apr 24
4
Kinnate Biopharma Inc.
5 Apr 24
144
Zentalis Pharmaceuticals, Inc.
12 Feb 24
4
Zentalis Pharmaceuticals, Inc.
12 Feb 24
4
Zentalis Pharmaceuticals, Inc.
5 Feb 24
144
Zentalis Pharmaceuticals, Inc.
2 Feb 24
4
Roivant Sciences Ltd.
23 Jan 24
4
Roivant Sciences Ltd.
18 Oct 23
4
Zentalis Pharmaceuticals, Inc.
6 Oct 23
144
Zentalis Pharmaceuticals, Inc.
4 Oct 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Apr 24 | ROIV Roivant Sciences | Common Shares | Payment of exercise | Dispose F | No | No | 10.9 | 123 | 1.34 k | 22,561 |
24 Apr 24 | ROIV Roivant Sciences | Common Shares | Grant | Acquire A | No | No | 0 | 1,146 | 0.00 | 22,684 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 24.46 | 20,250 | 495.32 k | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.48 | 25,000 | 87.00 k | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.38 | 20,250 | 169.70 k | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.39 | 60,751 | 509.70 k | 0 |
12 Feb 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 11.44 | 2,573 | 29.44 k | 451,449 |
2 Feb 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 11.54 | 8,669 | 100.04 k | 454,022 |
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 462,691 |
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 11.69 | 75,000 | 876.75 k | 75,000 |